Medication info
Candequr Tablets 8 mg (Candesartan Cilexetil)

Candequr Tablets 8 mg (Candesartan Cilexetil)

Prescription medicationTabletOral
Ingredient · strength
Candesartan Cilexetil›8mg / 1 tablet
Manufacturer / importer
Teragen Etex Co., Ltd.
Appearance
Light pink, biconvex, round tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201903456 · Approved 2019.05.28 · Insurance code 671707180

Summary

Main use
Treatment of essential hypertension and heart failure with reduced left ventricular systolic function
Who takes it
Adults · Children
Adult dose
Directions for use: Take this medicine at the same time every day, with or without food. 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, other treatments should be considered. The maximum effect is achieved within 4 weeks of starting treatment. 2) Elderly patients: No adjustment of the initial dose is necessary. 3) Patients with intravascular volume depletion: For patients at increased risk of hypotension, such as those with reduced effective circulating blood volume, administer an initial dose of 4 mg with careful monitoring. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those on hemodialysis, is 4 mg; adjust the dose according to the patient's response. There is limited experience with use in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min). 5) Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience with use in patients with severe hepatic impairment. 2. Heart failure 1) Adults: An initial dose of 4 mg once daily is recommended. Double the dose at intervals of at least 2 weeks, and increase it to a maximum of 32 mg once daily according to the patient's tolerability. 2) Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild ∼ moderate hepatic impairment: No adjustment of the initial dose is necessary.
Child dose
1. Essential hypertension 6) Children: The safety and efficacy of this medicine have not been established in adolescents and children 18 years of age or younger. 2. Heart failure 3) Children: The safety and efficacy of this medicine have not been established in adolescents and children 18 years of age or younger.

Ingredients

Manufacturer
Teragen Etex Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and heart failure with reduced left ventricular systolic function

  • Essential hypertension
  • heart failure
  • impaired left ventricular systolic function
  • decreased left ventricular ejection fraction
View approved original text

This medication is used to control blood pressure in patients with essential hypertension. Additionally, it helps improve symptoms of heart failure in patients with impaired left ventricular systolic function who require adjunct therapy with ACE inhibitors or who are intolerant to ACE inhibitors.

How to take

Adult dose

Directions for use: Take this medicine at the same time every day, with or without food. 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, other treatments should be considered. The maximum effect is achieved within 4 weeks of starting treatment. 2) Elderly patients: No adjustment of the initial dose is necessary. 3) Patients with intravascular volume depletion: For patients at increased risk of hypotension, such as those with reduced effective circulating blood volume, administer an initial dose of 4 mg with careful monitoring. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those on hemodialysis, is 4 mg; adjust the dose according to the patient's response. There is limited experience with use in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min). 5) Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience with use in patients with severe hepatic impairment. 2. Heart failure 1) Adults: An initial dose of 4 mg once daily is recommended. Double the dose at intervals of at least 2 weeks, and increase it to a maximum of 32 mg once daily according to the patient's tolerability. 2) Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild ∼ moderate hepatic impairment: No adjustment of the initial dose is necessary.

Child dose

1. Essential hypertension 6) Children: The safety and efficacy of this medicine have not been established in adolescents and children 18 years of age or younger. 2. Heart failure 3) Children: The safety and efficacy of this medicine have not been established in adolescents and children 18 years of age or younger.

Precautions

This medication can cause serious harm to the fetus, especially in the second and third trimesters of pregnancy, so it should be discontinued immediately if pregnancy is confirmed. This medication should not be taken by individuals allergic to this drug or its ingredients, women who are pregnant or may become pregnant, those who are breastfeeding, and individuals with severe liver disease or bile obstruction. Patients with hereditary angioedema or a history of angioedema while using ACE inhibitors or angiotensin II receptor antagonists, as well as those with primary hyperaldosteronism, should also not take this medication. Persons with genetic disorders such as lactase deficiency, Lapp lactase deficiency, or glucose-galactose malabsorption should avoid using this drug. Elderly patients, those with hyperkalemia, patients with liver disease, individuals with certain heart valve diseases or cardiomyopathy, and those with ischemic heart disease or cerebrovascular disorders should use this medication with caution. Patients with impaired kidney function or those who have received a kidney transplant, as well as adolescents and children under 18, should be cautious. Side effects may include dizziness, back pain, and respiratory infections, and rarely serious blood disorders, liver dysfunction, muscle pain, or kidney damage may occur. Particularly in heart failure patients, hypotension, hyperkalemia, and worsening kidney function may occur, thus regular blood tests are necessary. This medication should be taken with caution if used with other antihypertensives as the blood pressure-lowering effect may be increased, and particular caution is recommended when used in conjunction with potassium-sparing diuretics or potassium supplements, as this can dangerously raise serum potassium levels, warranting careful monitoring. Women who are pregnant or planning to become pregnant should not take this medication and breastfeeding women are advised to discontinue breastfeeding when taking this medication. In case of overdose, symptoms such as hypotension, dizziness, and rapid heartbeat may occur, and immediate consultation with a healthcare provider is necessary, as this drug is not removed by hemodialysis, thus requiring appropriate emergency management. Keep out of reach of children, and avoid transferring the medication to other containers as it may affect product quality. Caution is advised as dizziness may occur when driving or operating machinery.

Side effects

  • Dizziness
  • Low back pain
  • Respiratory infection
  • Weakness
  • Fever
  • Sensory disturbance
  • Indigestion
  • Gastroenteritis
  • Tachycardia
  • Palpitations
Show 67 more
  • Increased creatine kinase
  • Hyperglycemia
  • Hypertriglyceridemia
  • Hyperuricemia
  • Myalgia
  • Nasal bleeding
  • Anxiety
  • Depression
  • Sleepiness
  • Dyspnea
  • Rash
  • Increased sweating
  • Hematuria
  • Hypotension
  • Hyperkalemia
  • Renal function impairment
  • Increased creatinine
  • Increased urea
  • Fatigue
  • Peripheral edema
  • Chest pain
  • Headache
  • Bronchitis
  • Cough
  • Sinusitis
  • Nausea
  • Abdominal pain
  • Diarrhea
  • Vomiting
  • Arthralgia
  • Proteinuria
  • Leukopenia
  • Neutropenia
  • Agranulocytosis
  • Hyponatremia
  • Hypoglycemia
  • Intestinal vascular edema
  • Increased liver enzyme levels
  • Hepatitis
  • Increased AST
  • Increased ALT
  • Increased γ-GTP
  • Jaundice
  • Urticaria
  • Pruritus
  • Angioedema
  • Rhabdomyolysis
  • Increased myoglobin
  • Acute renal failure
  • Interstitial pneumonia
  • Shock
  • Syncope
  • Loss of consciousness
  • Paralysis
  • Hypertonia
  • Facial flushing
  • Weight gain
  • Facial edema
  • Thirst
  • Sleep disturbances
  • Decreased libido
  • Amnesia
  • Loss of appetite
  • Increased appetite
  • Tinnitus
  • Dysgeusia
  • Erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to avoid exposure to air or moisture. Additionally, it is best to store it at room temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness.

Appearance and packaging

Appearance

Light pink, biconvex, round tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.